CEO: | Daniel Lee |
CFO: | David Cocke |
Independent Non-Executive Director: | Brian Phillips |
Independent Non-Executive Director: | Trevor Phillips |
Non-Executive Chairman: | Jonathan Glenn |
Non-Executive Dir: | Shervanthi Homer - Vanniasinkam |
Address: | Unit 3, Phoenix Court, Lotherton Way, Garforth, United Kingdom, LS25 2GY |
Phone: | +44 (0) 1904 567 609 |
Fax: | +44 (0) 1904 380 517 |
Website: | http://www.tissueregenix.com/ |
Sector: | Financials(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BNTXR104 |
Currency | UK Pounds |
Share Price | 61.50p |
Change Today | 1.70p |
% Change | 2.84 % |
52 Week High | 71.50 |
52 Week Low | 49.00 |
Volume | 118 |
Shares Issued | 70.57m |
Market Cap | £43.40m |
RiskGrade | 22 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:52 | 50 @ 61.05p |
10:01 | 68 @ 61.05p |
You are here: research